Table of Contents
Three cell and gene therapy products now exceed $1 billion in annual global sales – proof that one-time, potentially curative treatments work at commercial scale.
Over 400 organisations across 25 countries are racing to bring these therapies to patients with otherwise untreatable diseases.
The Alliance for Regenerative Medicine is the leading global advocacy organisation for cell and gene therapies. Its flagship Cell & Gene Meeting on the Med, held at the Rome Cavalieri in April 2026, brought 45+ leading developers together for three days of partnering and commercialisation strategy, while ARM's quarterly Sector Snapshot reports track every clinical readout, financing round and regulatory decision shaping the field.
At Meeting on the Med 2026, reporting for Onyx, Federico Citterich sat down with Stephen Majors to find out more.
A special thanks to our Onyx Live sponsors:
Cellares - delivering cell therapy manufacturing excellence at scale across a global network of IDMO smart factories https://www.cellares.com/
Comments